Skip to content
Download PDF

Hypoxia and Cyanosis

Chapter 42 | Part 2: Cardinal Manifestations and Presentation of Diseases · Part 2 – Cardinal Manifestations & Presentation

Detailed clinical reference synthesised from Harrison's Principles of Internal Medicine, 22nd Edition

🔑 Key Clinical Points

  1. Cyanosis becomes apparent when the concentration of reduced hemoglobin in capillary blood exceeds 40 g/L (4 g/dL).
  2. Hypoxia-inducible factor-1 (HIF-1) governs the upregulation of glycolytic enzymes, glucose transporters (Glut-1, Glut-2), VEGF, and erythropoietin.
  3. High-altitude illness develops at ~3000 m (~10,000 ft) where alveolar PO2 decreases to ~60 mmHg.
  4. Anemic hypoxia: PAO2 is normal, but absolute O2 transport is diminished; cyanosis is often absent due to low total hemoglobin.
  5. Cyanide poisoning causes histotoxic hypoxia by impairing electron transport in mitochondria, limiting oxidative phosphorylation.
  6. Central cyanosis is caused by decreased arterial oxygen saturation (SaO2) or abnormal hemoglobin derivatives.
  7. Peripheral cyanosis is due to slowing of blood flow and abnormally great extraction of O2 from normally saturated arterial blood.
  8. High-altitude cerebral edema (HACE) is manifest by severe headache and papilledema and can cause coma.
  9. In patients with severe anemia, even marked arterial desaturation may not display cyanosis due to low absolute quantity of reduced hemoglobin.
  10. Patients with marked polycythemia tend to be cyanotic at higher levels of SaO2 than patients with normal hematocrit values.

📑 Table of Contents

1. DEFINITION & OVERVIEW

The fundamental purpose of the cardiorespiratory system is to deliver O2 and nutrients to cells and to remove CO2 and other metabolic products from them. Proper maintenance of this function depends not only on intact cardiovascular and respiratory systems, but also on an adequate number of red blood cells and hemoglobin, and a supply of inspired gas containing adequate O2.

1.1 Hypoxia

Harrison's defines hypoxia as a condition where decreased O2 availability to cells typically results in an inhibition of oxidative phosphorylation and increased anaerobic glycolysis. This switch from aerobic to anaerobic metabolism, the Pasteur effect, reduces the yield of adenosine 5′-triphosphate (ATP) produced per mole of glucose.

1.2 Cyanosis

Cyanosis refers to a bluish color of the skin and mucous membranes resulting from an increased quantity of reduced hemoglobin (i.e., deoxygenated hemoglobin) or of hemoglobin derivatives (e.g., methemoglobin or sulfhemoglobin) in the small blood vessels of those tissues. It is usually most marked in the lips, nail beds, ears, and malar eminences.

2. EPIDEMIOLOGY

The text does not provide specific epidemiological data for general hypoxia or cyanosis. However, it notes that chronic mountain sickness develops in persons with chronic hypoxemia secondary to prolonged residence at a high altitude (>13,000 ft, 4200 m).

3. ETIOLOGY & PATHOPHYSIOLOGY

Hypoxia is categorized into several types based on the underlying mechanism: Respiratory, Circulatory, High Altitude, Histotoxic, and Anemic.

3.1 Respiratory Hypoxia

When hypoxia occurs from respiratory failure, PAO2 declines. When respiratory failure is persistent, the hemoglobin-oxygen (Hb-O) dissociation curve is displaced to the right, with greater quantities of O2 released at any level of tissue PO2. Arterial hypoxemia is likely to be more marked when such depression of PAO2 results from pulmonary disease than when the depression occurs as the result of a decline in the fraction of oxygen in inspired air (FiO2).

3.2 Circulatory Hypoxia

Generalized circulatory hypoxia occurs in heart failure and in most forms of shock. Localized circulatory hypoxia may occur as a result of decreased perfusion secondary to arterial obstruction (e.g., localized atherosclerosis in any vascular bed) or vasoconstriction (e.g., Raynaud's phenomenon). Localized hypoxia may also result from venous obstruction and the resultant expansion of interstitial fluid causing arteriolar compression and, thereby, reduction of arterial inflow.

3.3 Hypoxia Secondary to High Altitude

As one ascends rapidly to 3000 m (~10,000 ft), the reduction of the O2 content of inspired air (FiO2) leads to a decrease in alveolar PO2 to ~60 mmHg, and a condition termed high-altitude illness develops. At higher altitudes, arterial saturation declines rapidly and symptoms become more severe; and at 5000 m, unacclimated individuals usually cease to be able to function normally owing to the changes in CNS function described above. This condition has been termed histotoxic hypoxia.

3.4 Increased O2 Requirements

If the O2 consumption of tissues is elevated without a corresponding increase in perfusion, tissue hypoxia ensues and the PO2 in venous blood declines. Ordinarily, the clinical picture of patients with hypoxia due to an elevated metabolic rate, as in fever or thyrotoxicosis, is quite different from that in other types of hypoxia: the skin is warm and flushed owing to increased cutaneous blood flow that dissipates the excessive heat produced, and cyanosis is usually absent.

3.5 Improper Oxygen Utilization

Cyanide and several other similarly acting poisons cause cellular hypoxia by impairing electron transport in mitochondria, thereby limiting oxidative phosphorylation and ATP production. The tissues are unable to use O2, and as a consequence, the venous blood tends to have a high O2 tension. This condition has been termed histotoxic hypoxia.

3.6 Anemic Hypoxia

A reduction in hemoglobin concentration of the blood is accompanied by a corresponding decline in the O2-carrying capacity of the blood. Although the PAO2 is normal in anemic hypoxia, the absolute quantity of O2 transported per unit volume of blood is diminished. As the anemic blood passes through the capillaries and the usual quantity of O2 is removed from it, the PO2 and saturation in the venous blood decline to a greater extent than normal.

3.7 Carbon Monoxide (CO) Intoxication

Hemoglobin that binds CO (carboxy-hemoglobin [COHb]) is unavailable for O2 transport. In addition, the presence of COHb shifts the Hb-O dissociation curve to the left so that O2 is unloaded only at lower tensions, further contributing to tissue hypoxia.

3.8 Hypoxia Secondary to Right-to-Left Shunting

From a physiologic viewpoint, this cause of hypoxia resembles intrapulmonary right-to-left shunting but is caused by congenital cardiac malformations, such as tetralogy of Fallot, transposition of the great arteries, atrial or ventricular septal defect, patent ductus arteriosus, and Eisenmenger's syndrome. As in pulmonary right-to-left shunting, the PAO2 cannot be restored to normal with inspiration of 100% O2.

4. CLINICAL FEATURES

Changes in the central nervous system (CNS) function, particularly the higher centers, are especially important consequences of hypoxia. Acute hypoxia causes impaired judgment, motor incoordination, and a clinical picture resembling acute alcohol intoxication.

4.1 High-Altitude Illness

High-altitude illness is characterized by headache secondary to cerebral vasodilation, gastrointestinal symptoms, dizziness, insomnia, fatigue, or somnolence. Pulmonary arterial and sometimes venous constriction causes capillary leakage and high-altitude pulmonary edema (HAPE), which intensifies hypoxia, further promoting vasoconstriction. Rarely, high-altitude cerebral edema (HACE) develops, which is manifest by severe headache and papilledema, and can cause coma. As hypoxia becomes more severe, the regulatory centers of the brainstem are affected, and death usually results from respiratory failure.

4.2 Cardiovascular Effects

Acute hypoxia stimulates the chemoreceptor reflex arc to induce venoconstriction and systemic arterial vasodilation. These acute changes are accompanied by transiently increased myocardial contractility, which is followed by depressed myocardial contractility with prolonged hypoxia. In patients with underlying heart disease, the requirements of peripheral tissues for an increase of cardiac output with hypoxia may precipitate congestive heart failure. In patients with ischemic heart disease, a reduced PAO2 may intensify myocardial ischemia and further impair left ventricular function.

4.3 Cyanosis Presentation

Cyanosis may be subdivided into central and peripheral types. In central cyanosis, the SaO2 is reduced or an abnormal hemoglobin derivative is present, and the mucous membranes and skin are both affected. Peripheral cyanosis is due to a slowing of blood flow and abnormally great extraction of O2 from normally saturated arterial blood; it results from vasoconstriction and diminished peripheral blood flow, such as occurs in cold exposure, shock, congestive failure, and peripheral vascular disease. Often in these conditions, the mucous membranes of the oral cavity, including the sublingual mucosa, may be spared.

5. DIFFERENTIAL DIAGNOSIS

Decreased SaO2 results from a marked reduction in the PAO2. This reduction may be brought about by a decline in the FiO2 without sufficient compensatory alveolar hyperventilation to maintain alveolar PO2. Cyanosis usually becomes manifest in an ascent to an altitude of 4000 m (13,000 ft).

5.1 Central Cyanosis Causes

Causes include decreased atmospheric pressure (high altitude), impaired pulmonary function, alveolar hypoventilation, inhomogeneity in pulmonary ventilation and perfusion (perfusion of hypoventilated alveoli), impaired oxygen diffusion, anatomic shunts, certain types of congenital heart disease, pulmonary arteriovenous fistulas, multiple small intrapulmonary shunts, hemoglobin with low affinity for oxygen, and hemoglobin abnormalities (methemoglobinemia, sulfhemoglobinemia, carboxyhemoglobinemia).

5.2 Peripheral Cyanosis Causes

Causes include reduced cardiac output, cold exposure, redistribution of blood flow from extremities, arterial obstruction, and venous obstruction.

6. INVESTIGATIONS & DIAGNOSIS

The text does not provide a specific diagnostic algorithm for hypoxia or cyanosis beyond the clinical definitions and thresholds. Diagnostic studies for initial evaluation of related conditions (e.g., hemoptysis) include a complete blood count, coagulation studies, basic metabolic panel, and urinalysis. Infectious workup (including bacterial sputum culture, acid-fast bacillus culture, and respiratory viral panel) and serologic workup (including antinuclear antibody, antineutrophilic cytoplasmic antibody, and anti-GBM) can be obtained if indicated.

6.1 Diagnostic Criteria for Cyanosis

Cyanosis becomes apparent when the concentration of reduced hemoglobin in capillary blood exceeds 40 g/L (4 g/dL).

6.2 High-Altitude Diagnostic Thresholds

At 3000 m (~10,000 ft), the reduction of the O2 content of inspired air (FiO2) leads to a decrease in alveolar PO2 to ~60 mmHg. At 5000 m, unacclimated individuals usually cease to be able to function normally.

7. MANAGEMENT & TREATMENT

Management focuses on the underlying cause. For respiratory hypoxia, correcting the underlying pulmonary disease or improving ventilation is key. For high-altitude illness, descent is the primary treatment. For cyanosis due to hemoglobin abnormalities, specific antidotes or transfusions may be required.

7.1 High-Altitude Illness Management

Symptomatic treatment includes descent to lower altitude and administration of supplemental oxygen. For HAPE, descent and oxygen are critical. For HACE, dexamethasone may be used, though specific dosing is not detailed in this text.

7.2 Adaptation to Hypoxia

One of the important compensatory mechanisms for chronic hypoxia is an increase in the hemoglobin concentration and in the number of red blood cells in the circulating blood, that is, the development of polycythemia induced by erythropoietin production. In persons with chronic hypoxemia secondary to prolonged residence at a high altitude (>13,000 ft, 4200 m), a condition termed chronic mountain sickness develops.

8. PROGNOSIS & COMPLICATIONS

In high-altitude illness, death usually results from respiratory failure if hypoxia becomes severe enough to affect the regulatory centers of the brainstem. Chronic mountain sickness is characterized by right ventricular enlargement secondary to pulmonary hypertension and even stupor.

8.1 High-Altitude Complications

High-altitude pulmonary edema (HAPE) intensifies hypoxia, further promoting vasoconstriction. High-altitude cerebral edema (HACE) can cause coma.

9. SPECIAL CONSIDERATIONS

The text specifically addresses high-altitude considerations. It notes that in patients with underlying heart disease, the requirements of peripheral tissues for an increase of cardiac output with hypoxia may precipitate congestive heart failure. In patients with ischemic heart disease, a reduced PAO2 may intensify myocardial ischemia and further impair left ventricular function.

9.1 Cardiac Disease

Patients with underlying heart disease or ischemic heart disease are at higher risk for complications of hypoxia, including congestive heart failure and intensified myocardial ischemia.

10. KEY PEARLS & CLINICAL TRAPS

Cyanosis is often detected by family members before the patient. The absolute quantity of reduced hemoglobin is more important than the relative quantity. Anemia masks cyanosis; polycythemia enhances it. Carboxyhemoglobinemia presents with a cherry-colored flush, not true cyanosis.

Generated from Harrison's Principles of Internal Medicine, 22nd Edition.